EXCLUSIVE: FibroBiologics Announces First Patients Dosed In Phase 1/2 Clinical Trial for Diabetic Foot Ulcers; CYWC628 Is Multicenter Phase 1/2 Clinical Study of Fibroblast Cell Therapy In Australia

뉴스 본문을 불러오고 있어요.

EXCLUSIVE: FibroBiologics Announces First Patients Dosed In Phase 1/2 Clinical Trial for Diabetic Foot Ulcers; CYWC628 Is Multicenter Phase 1/2 Clinical Study of Fibroblast Cell Therapy In Australia | 웨이프 WAPE

EXCLUSIVE: FibroBiologics Announces First Patients Dosed In Phase 1/2 Clinical Trial for Diabetic Foot Ulcers; CYWC628 Is Multicenter Phase 1/2 Clinical Study of Fibroblast Cell Therapy In Australia

기사 요약

관련 종목

댓글 —